$CAH
CARDINAL HEALTH INC Stock $cah

$cah Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000072137123000084 Filed on November 03, 2023

Income Statement

Concept	2023 Q4	2023 Q3
Revenue	$57.45B	$54.76B
YoY Change	11.61%	10.4%
Cost Of Revenue	$55.60B	$53.00B
YoY Change	11.63%	10.43%
Gross Profit	$1.846B	$1.768B
YoY Change	11.0%	9.54%
Gross Profit Margin	3.21%	3.23%
Selling, General & Admin	$1.283B	$1.197B
YoY Change	7.72%	0.0%
% of Gross Profit	69.5%	67.7%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$175.0M	$172.0M
YoY Change	2.94%	0.58%
% of Gross Profit	9.48%	9.73%
Operating Expenses	$1.283B	$1.197B
YoY Change	7.72%	0.0%
Operating Profit	$482.0M	-$14.00M
YoY Change	-505.04%	-110.22%
Interest Expense	$8.000M	$14.00M
YoY Change	-68.0%	-44.0%
% of Operating Profit	1.66%
Other Income/Expense, Net	$16.00M	$2.000M
YoY Change	128.57%	-200.0%
Pretax Income	$490.0M	-$26.00M
YoY Change	-457.66%	-123.64%
Income Tax	$136.0M	-$32.00M
% Of Pretax Income	27.76%
Net Earnings	$353.0M	$5.000M
YoY Change	-371.54%	-95.45%
Net Earnings / Revenue	0.61%	0.01%
Basic Earnings Per Share	$1.50	$0.02
Diluted Earnings Per Share	$1.44	$0.02
COMMON SHARES
Basic Shares Outstanding	246.5M shares	250.7M shares
Diluted Shares Outstanding	246.0M shares	250.0M shares

Balance Sheet

Concept	2023 Q4	2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$4.591B	$3.854B
YoY Change	25.64%	10.37%
Cash & Equivalents	$4.591B	$3.854B
Short-Term Investments
Other Short-Term Assets	$2.816B	$2.582B
YoY Change	24.71%	13.54%
Inventory	$18.45B	$16.99B
Prepaid Expenses
Receivables	$11.79B	$11.27B
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$37.66B	$34.69B
YoY Change	8.85%	6.09%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.446B	$2.441B
YoY Change	4.49%	4.36%
Goodwill	$4.024B	$4.025B
YoY Change	-19.29%	-29.07%
Intangibles	$1.347B	$1.407B
YoY Change	-17.46%	-16.84%
Long-Term Investments
YoY Change
Other Assets	$1.098B	$1.149B
YoY Change	18.45%	16.65%
Total Long-Term Assets	$8.915B	$9.022B
YoY Change	-9.82%	-15.61%
TOTAL ASSETS
Total Short-Term Assets	$37.66B	$34.69B
Total Long-Term Assets	$8.915B	$9.022B
Total Assets	$46.57B	$43.71B
YoY Change	4.7%	0.74%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$34.26B	$31.54B
YoY Change	13.88%	11.21%
Accrued Expenses	$2.839B	$2.737B
YoY Change	11.25%	4.51%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$1.188B	$788.0M
YoY Change	105.89%	36.33%
Total Short-Term Liabilities	$38.29B	$35.07B
YoY Change	15.28%	11.11%
LONG-TERM LIABILITIES
Long-Term Debt	$3.535B	$3.890B
YoY Change	-24.55%	-17.04%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$3.535B	$3.890B
YoY Change	-24.55%	-17.04%
TOTAL LIABILITIES
Total Short-Term Liabilities	$38.29B	$35.07B
Total Long-Term Liabilities	$3.535B	$3.890B
Total Liabilities	$50.02B	$47.20B
YoY Change	7.13%	4.5%
SHAREHOLDERS EQUITY
Retained Earnings	-$425.0M	-$654.0M
YoY Change	-24.11%	117.28%
Common Stock	$2.855B	$2.728B
YoY Change	3.93%	5.9%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$5.724B	$5.400B
YoY Change	34.56%	39.18%
Treasury Stock Shares
Shareholders Equity	-$3.449B	-$3.491B
YoY Change
Total Liabilities & Shareholders Equity	$46.57B	$43.71B
YoY Change	4.7%	0.74%

Cashflow Statement

Concept	2023 Q4	2023 Q3
OPERATING ACTIVITIES
Net Income	$353.0M	$5.000M
YoY Change	-371.54%	-95.45%
Depreciation, Depletion And Amortization	$175.0M	$172.0M
YoY Change	2.94%	0.58%
Cash From Operating Activities	$1.189B	$545.0M
YoY Change	99.16%	2269.57%
INVESTING ACTIVITIES
Capital Expenditures	$114.0M	$92.00M
YoY Change	-234.12%	31.43%
Acquisitions
YoY Change
Other Investing Activities	$9.000M	$29.00M
YoY Change	-550.0%
Cash From Investing Activities	-$105.0M	-$63.00M
YoY Change	20.69%	-10.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net		$7.000M
YoY Change		0.0%
Cash From Financing Activities	-353.0M	-$666.0M
YoY Change	-2.49%	-42.73%
NET CHANGE
Cash From Operating Activities	1.189B	$545.0M
Cash From Investing Activities	-105.0M	-$63.00M
Cash From Financing Activities	-353.0M	-$666.0M
Net Change In Cash	731.0M	-$189.0M
YoY Change	393.92%	-84.57%
FREE CASH FLOW
Cash From Operating Activities	$1.189B	$545.0M
Capital Expenditures	$114.0M	$92.00M
Free Cash Flow	$1.075B	$453.0M
YoY Change	57.62%	-1063.83%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	52995000000	usd
CY2022Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	47989000000	usd
CY2022Q3	us-gaap	Gross Profit GrossProfit	1614000000	usd
CY2022Q3	cah	Amortizationandotheracquisitionrelatedcosts Amortizationandotheracquisitionrelatedcosts	71000000	usd
CY2023Q3	us-gaap	Gain Loss On Sales Of Assets And Asset Impairment Charges GainLossOnSalesOfAssetsAndAssetImpairmentCharges	-537000000	usd
CY2022Q3	us-gaap	Gain Loss On Sales Of Assets And Asset Impairment Charges GainLossOnSalesOfAssetsAndAssetImpairmentCharges	-153000000	usd
CY2023Q3	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	41000000	usd
CY2022Q3	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-27000000	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-14000000	usd
CY2023Q3	us-gaap	Disposal Group Not Discontinued Operation Gain Loss On Disposal Statement Of Income Extensible List DisposalGroupNotDiscontinuedOperationGainLossOnDisposalStatementOfIncomeExtensibleList	http://fasb.org/us-gaap/2023#GainLossOnSalesOfAssetsAndAssetImpairmentCharges
CY2023Q3	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q3	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023Q3	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023Q3	us-gaap	Revenues Revenues	54763000000	usd
CY2022Q3	us-gaap	Revenues Revenues	49603000000	usd
CY2023Q3	us-gaap	Restructuring Charges RestructuringCharges	25000000	usd
CY2023Q3	cah	Amortizationandotheracquisitionrelatedcosts Amortizationandotheracquisitionrelatedcosts	64000000	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	137000000	usd
CY2023Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2000000	usd
CY2022Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-2000000	usd
CY2023Q3	us-gaap	Interest Expense InterestExpense	14000000	usd
CY2022Q3	us-gaap	Interest Expense InterestExpense	25000000	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-26000000	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	110000000	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-32000000	usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1000000	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	6000000	usd
CY2022Q3	us-gaap	Profit Loss ProfitLoss	111000000	usd
CY2023Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1000000	usd
CY2022Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1000000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	5000000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	110000000	usd
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.02
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.41
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.02
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.40
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	249000000	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	271000000	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	250000000	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	273000000	shares
CY2023Q3	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.5006
CY2022Q3	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.4957
CY2023Q3	us-gaap	Profit Loss ProfitLoss	6000000	usd
CY2022Q3	us-gaap	Profit Loss ProfitLoss	111000000	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-11000000	usd
CY2022Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-58000000	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	-3000000	usd
CY2022Q3	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	-4000000	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-14000000	usd
CY2022Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-62000000	usd
CY2023Q3	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-8000000	usd
CY2022Q3	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	49000000	usd
CY2022Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1000000	usd
CY2023Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-9000000	usd
CY2022Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	48000000	usd
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3854000000	usd
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4043000000	usd
CY2023Q3	us-gaap	Receivables Net Current ReceivablesNetCurrent	11265000000	usd
CY2023Q2	us-gaap	Receivables Net Current ReceivablesNetCurrent	11344000000	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	16987000000	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	15940000000	usd
CY2023Q3	us-gaap	Other Assets Current OtherAssetsCurrent	2582000000	usd
CY2023Q2	us-gaap	Other Assets Current OtherAssetsCurrent	2362000000	usd
CY2023Q3	us-gaap	Assets Of Disposal Group Including Discontinued Operation AssetsOfDisposalGroupIncludingDiscontinuedOperation	0	usd
CY2023Q2	us-gaap	Assets Of Disposal Group Including Discontinued Operation AssetsOfDisposalGroupIncludingDiscontinuedOperation	144000000	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	34688000000	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	33833000000	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2441000000	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2462000000	usd
CY2023Q3	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	5432000000	usd
CY2023Q2	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	6081000000	usd
CY2023Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1149000000	usd
CY2023Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1041000000	usd
CY2023Q3	us-gaap	Assets Assets	43710000000	usd
CY2023Q2	us-gaap	Assets Assets	43417000000	usd
CY2023Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	31540000000	usd
CY2023Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	29813000000	usd
CY2023Q3	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	788000000	usd
CY2023Q2	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	792000000	usd
CY2023Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2737000000	usd
CY2023Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	3059000000	usd
CY2023Q3	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation	0	usd
CY2023Q2	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation	42000000	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	35065000000	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	33706000000	usd
CY2023Q3	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	3890000000	usd
CY2023Q2	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	3909000000	usd
CY2023Q3	us-gaap	Deferred Tax And Other Liabilities Noncurrent DeferredTaxAndOtherLiabilitiesNoncurrent	8245000000	usd
CY2023Q2	us-gaap	Deferred Tax And Other Liabilities Noncurrent DeferredTaxAndOtherLiabilitiesNoncurrent	8653000000	usd
CY2023Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	500000	shares
CY2023Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	500000	shares
CY2023Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	755000000	shares
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	755000000	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	327000000	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	327000000	shares
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	2728000000	usd
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	2747000000	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-654000000	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-534000000	usd
CY2023Q3	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	80000000	shares
CY2023Q2	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	76000000	shares
CY2023Q3	us-gaap	Treasury Stock Value TreasuryStockValue	5400000000	usd
CY2023Q2	us-gaap	Treasury Stock Value TreasuryStockValue	4914000000	usd
CY2023Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-165000000	usd
CY2023Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-151000000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	-3491000000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-2852000000	usd
CY2023Q3	us-gaap	Minority Interest MinorityInterest	1000000	usd
CY2023Q2	us-gaap	Minority Interest MinorityInterest	1000000	usd
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-3490000000	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-2851000000	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	43710000000	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	43417000000	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-2851000000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	5000000	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	6000000	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-14000000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	0	usd
CY2023Q3	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	505000000	usd
CY2023Q3	us-gaap	Dividends Dividends	125000000	usd
CY2023Q3	us-gaap	Stockholders Equity Other StockholdersEquityOther	-1000000	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-706000000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	110000000	usd
CY2022Q3	us-gaap	Profit Loss ProfitLoss	111000000	usd
CY2022Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-62000000	usd
CY2022Q3	us-gaap	Minority Interest Decrease From Redemptions MinorityInterestDecreaseFromRedemptions	2000000	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	11000000	usd
CY2022Q3	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	1000000000	usd
CY2022Q3	us-gaap	Dividends Dividends	131000000	usd
CY2022Q3	us-gaap	Stockholders Equity Other StockholdersEquityOther	-1000000	usd
CY2022Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-1780000000	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	6000000	usd
CY2022Q3	us-gaap	Profit Loss ProfitLoss	111000000	usd
CY2023Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	172000000	usd
CY2022Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	171000000	usd
CY2023Q3	us-gaap	Gain Loss On Sales Of Assets And Asset Impairment Charges GainLossOnSalesOfAssetsAndAssetImpairmentCharges	-537000000	usd
CY2022Q3	us-gaap	Gain Loss On Sales Of Assets And Asset Impairment Charges GainLossOnSalesOfAssetsAndAssetImpairmentCharges	-153000000	usd
CY2023Q3	us-gaap	Share Based Compensation ShareBasedCompensation	29000000	usd
CY2022Q3	us-gaap	Share Based Compensation ShareBasedCompensation	23000000	usd
CY2023Q3	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	29000000	usd
CY2022Q3	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	29000000	usd
CY2023Q3	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-50000000	usd
CY2022Q3	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	508000000	usd
CY2023Q3	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1057000000	usd
CY2022Q3	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	264000000	usd
CY2023Q3	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1727000000	usd
CY2022Q3	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1234000000	usd
CY2023Q3	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	948000000	usd
CY2022Q3	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	926000000	usd
CY2023Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	545000000	usd
CY2022Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	23000000	usd
CY2023Q3	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	92000000	usd
CY2022Q3	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	70000000	usd
CY2023Q3	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	1000000	usd
CY2022Q3	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	2000000	usd
CY2023Q3	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	1000000	usd
CY2022Q3	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	3000000	usd
CY2023Q3	cah	Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments	1000000	usd
CY2022Q3	cah	Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments	1000000	usd
CY2023Q3	us-gaap	Proceeds From Hedge Investing Activities ProceedsFromHedgeInvestingActivities	28000000	usd
CY2022Q3	us-gaap	Proceeds From Hedge Investing Activities ProceedsFromHedgeInvestingActivities	0	usd
CY2023Q3	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-63000000	usd
CY2022Q3	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-70000000	usd
CY2023Q3	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	7000000	usd
CY2022Q3	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	7000000	usd
CY2023Q3	cah	Netproceedstaxwithholdingsfromsharebasedcompensation Netproceedstaxwithholdingsfromsharebasedcompensation	-28000000	usd
CY2022Q3	cah	Netproceedstaxwithholdingsfromsharebasedcompensation Netproceedstaxwithholdingsfromsharebasedcompensation	-14000000	usd
CY2023Q3	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	131000000	usd
CY2022Q3	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	142000000	usd
CY2023Q3	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	500000000	usd
CY2022Q3	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1000000000	usd
CY2023Q3	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-666000000	usd
CY2022Q3	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1163000000	usd
CY2023Q3	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-5000000	usd
CY2022Q3	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-15000000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-189000000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1225000000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4043000000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4717000000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3854000000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3492000000	usd
CY2023Q3	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	12000000	usd
CY2023Q3	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	12000000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	4731000000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	3336000000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1395000000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Remaining Amortization Period1 FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1	P9Y
CY2023Q3	us-gaap	Severance Costs1 SeveranceCosts1	7000000	usd
CY2022Q3	us-gaap	Severance Costs1 SeveranceCosts1	19000000	usd
CY2023Q3	cah	Facility Exit And Other Costs FacilityExitAndOtherCosts	18000000	usd
CY2022Q3	cah	Facility Exit And Other Costs FacilityExitAndOtherCosts	10000000	usd
CY2023Q3	us-gaap	Restructuring Charges RestructuringCharges	25000000	usd
CY2022Q3	us-gaap	Restructuring Charges RestructuringCharges	29000000	usd
CY2023Q2	us-gaap	Restructuring Reserve RestructuringReserve	46000000	usd
CY2023Q3	us-gaap	Restructuring Costs RestructuringCosts	10000000	usd
CY2023Q3	us-gaap	Payments For Restructuring PaymentsForRestructuring	17000000	usd
CY2023Q3	us-gaap	Restructuring Reserve RestructuringReserve	39000000	usd
CY2023Q2	us-gaap	Goodwill Goodwill	4609000000	usd
CY2023Q3	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	3000000	usd
CY2023Q3	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	581000000	usd
CY2023Q3	us-gaap	Goodwill Goodwill	4025000000	usd
CY2023Q3	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	4743000000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	3336000000	usd
CY2023Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1407000000	usd
CY2023Q2	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	11000000	usd
CY2023Q2	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	11000000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	4741000000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	3280000000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1461000000	usd
CY2023Q2	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	4752000000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	3280000000	usd
CY2023Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1472000000	usd
CY2023Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	64000000	usd
CY2022Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	71000000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	190000000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	228000000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	205000000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	173000000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	146000000	usd
CY2023Q2	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	4700000000	usd
CY2023Q3	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	4700000000	usd
CY2023Q3	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	31500000000	usd
CY2023Q2	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	29800000000	usd
CY2023Q3	cah	Incomefrom Settlementsof Class Action Lawsuits IncomefromSettlementsofClassActionLawsuits	41000000	usd
CY2023Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	1.225
CY2022Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.007
CY2023Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	998000000	usd
CY2023Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1000000000	usd
CY2023Q3	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	872000000	usd
CY2023Q2	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	873000000	usd
CY2023Q3	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	68000000	usd
CY2023Q2	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	65000000	usd
CY2023Q3	us-gaap	Change In Unrealized Gain Loss On Fair Value Hedging Instruments1 ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1	0	usd
CY2022Q3	us-gaap	Revenues Revenues	49603000000	usd
CY2023Q3	cah	Carrying Amountof Long Termandother Short Term Borrowings CarryingAmountofLongTermandotherShortTermBorrowings	4678000000	usd
CY2023Q2	cah	Carrying Amountof Long Termandother Short Term Borrowings CarryingAmountofLongTermandotherShortTermBorrowings	4701000000	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	3000000	usd
CY2022Q3	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	7000000	usd
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	249000000	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	271000000	shares
CY2023Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	1000000	shares
CY2022Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	2000000	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	250000000	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	273000000	shares
CY2023Q3	cah	Numberofsharesexcludedfromcalculationofdilutedshares Numberofsharesexcludedfromcalculationofdilutedshares	1000000	shares
CY2022Q3	cah	Numberofsharesexcludedfromcalculationofdilutedshares Numberofsharesexcludedfromcalculationofdilutedshares	4000000	shares
CY2023Q3	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
CY2023Q3	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	segment
CY2023Q3	us-gaap	Revenues Revenues	54763000000	usd
CY2022Q3	us-gaap	Revenues Revenues	49603000000	usd
CY2023Q3	cah	Project Costs On Investment And Other Spending ProjectCostsOnInvestmentAndOtherSpending	6000000	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-14000000	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	137000000	usd
CY2023Q3	us-gaap	Assets Assets	43710000000	usd
CY2023Q2	us-gaap	Assets Assets	43417000000	usd
CY2023Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	29000000	usd
CY2022Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	23000000	usd
CY2023Q3	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	4000000	usd
CY2022Q3	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	3000000	usd

Files In Submission

Name	View Source	Status
0000721371-23-000084-index-headers.html	Edgar Link	pending
0000721371-23-000084-index.html	Edgar Link	pending
0000721371-23-000084.txt	Edgar Link	pending
0000721371-23-000084-xbrl.zip	Edgar Link	pending
R4.htm	Edgar Link	pending
a24q1_10qx093023xex31131.htm	Edgar Link	pending
a24q1_10qx093023xex31231.htm	Edgar Link	pending
a24q1_10qx093023xex32131.htm	Edgar Link	pending
a24q1_10qx093023xex99111.htm	Edgar Link	pending
a24q1_10qx093023xexhibit101.htm	Edgar Link	pending
a24q1_10qx093023xexhibit102.htm	Edgar Link	pending
cah-20230930.htm	Edgar Link	pending
cah-20230930.xsd	Edgar Link	pending
cah-20230930_g1.jpg	Edgar Link	pending
cah-20230930_g2.jpg	Edgar Link	pending
cah-20230930_g3.jpg	Edgar Link	pending
cah-20230930_g4.jpg	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
cah-20230930_htm.xml	Edgar Link	completed
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
cah-20230930_def.xml	Edgar Link	unprocessable
cah-20230930_cal.xml	Edgar Link	unprocessable
cah-20230930_pre.xml	Edgar Link	unprocessable
cah-20230930_lab.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CAH
CARDINAL HEALTH INC Stock $cah

2023 Q4 Form 10-Q Financial Statement

#000072137123000084 Filed on November 03, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CAH CARDINAL HEALTH INC Stock $cah

2023 Q4 Form 10-Q Financial Statement

#000072137123000084 Filed on November 03, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CAH
CARDINAL HEALTH INC Stock $cah